|Other Names||Ras association domain-containing protein 4, RASSF4|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP8942c was selected from the Center region of human RASSF4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Potential tumor suppressor. May act as a KRAS effector protein. May promote apoptosis and cell cycle arrest.|
|Tissue Location||Widely expressed. Frequently down-regulated in tumor cell lines.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The function of RASSF4 has not yet been determined but it may involve a role in tumor suppression. RASSF4 may act as a KRAS effector protein and may promote apoptosis and cell cycle arrest. Alternative splicing of this gene results in several transcript variants; however, most of the variants have not been fully described.
French,D., et.al., Blood 113 (19), 4512-4520 (2009)Grupe,A., et.al., Am. J. Hum. Genet. 78 (1), 78-88 (2006)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.